Arla sharpening its focus on innovation, nutrition, localization

Arla's infant nutrition segment has seen its Arla Baby & Me products perform robustly. Cross-border HMO (Human Milk Oligosaccharides) portfolio, led by its "5HMO Triple Self-Immune Formula," continues to perform strongly, while its organic A2 line is outpacing industry growth.

The company's Cocio chocolate milk products remain a consumer favorite due to their clean-label formula and caramelized flavor. The new coconut flavor, debuting globally at CIIE, reflects the company's strategy to tailor innovation to evolving Chinese tastes.

Its cheese business is also expanding, with upgraded flavors, refreshed packaging, and a focus on balancing indulgence and nutrition to meet shifting consumer preferences.

Arla said it will continue to use CIIE as a platform to showcase innovation, expand distribution, and invest in research and development in China.

"China represents a strategically important market within Arla's global growth agenda, particularly in early life nutrition," said Frede Juulsen, head of early life nutrition at Arla. "With strong R&D capabilities and a resilient supply chain, we're well-positioned to meet the evolving needs of Chinese families."